US shifts to T+1 settlement on May 28, 2024, replacing T+2 system. Benefits include improved liquidity, lower risk, but requires precise and timely processing of trades.
Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia.
Key Takeaways:
JD.com reported a profit of 7.1 billion yuan for the first quarter, up nearly 13% year-on-year
Many investment banks upwardly revised their price targets and ratings for the stock after the release of the latest report
By Lau Chi Hang
So-Young International Inc (NASDAQ: SY) reported Q1 2024 results, with revenue of $44.1M beating estimates. Mobile MAUs decreased while cash holdings were $186.3M.